|
|
Other links at Articles > Business of Medicine |
| 3. |
Medicare Coverage Decisions Often Based on Trials in Irrelevant Populations
|
|
|
The Centers for Medicaid and Medicare Services (CMS) often make national coverage determinations based on clinical trials among subjects whose demographics differ substantially from those of Medicare beneficiaries, according to researchers at the University of California at San Francisco School of Medicine. Reuters Health Information
|
| 4. |
FDA Approvals: Nexium, Humira, Xyntha
|
|
|
The FDA has approved an expanded indication for esomeprazole magnesium, a new indication for adalimumab subcutaneous injection, and antihemophilic factor plasma/albumin-free intravenous infusion. Medscape Medical News
|
| 5. |
Doctor vs. Scientist?
|
|
|
Can physician-investigators reconcile their therapeutic obligation to provide medical care for their patients with their research-based obligation to engage in sound scientific practice?
The Hastings Center Report
|
|
|
